Get the Stockscreener App
4.24
0.47%
-0.02
Protagenic Therapeutics Inc stock is traded at $4.24, with a volume of 2.25M.
It is down -0.47% in the last 24 hours and up +26.95% over the past month.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
See More
Previous Close:
$4.26
Open:
$3.92
24h Volume:
2.25M
Relative Volume:
1.30
Market Cap:
$2.50M
Revenue:
-
Net Income/Loss:
$-5.00M
P/E Ratio:
-3.687
EPS:
-1.15
Net Cash Flow:
$-3.85M
1W Performance:
+44.71%
1M Performance:
+26.95%
6M Performance:
+14.07%
1Y Performance:
-52.13%
1-Day Range:
$3.62
$4.4099
1-Week Range:
$2.25
$6.20
52-Week Range:
$2.25
$15.54
Protagenic Therapeutics Inc Stock (PTIX) Company Profile
Name
Protagenic Therapeutics Inc
Sector
Industry
Phone
(212) 994-8200
Address
149 FIFTH AVENUE, NEW YORK
Compare PTIX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PTIX
Protagenic Therapeutics Inc
|
4.24 | 2.41M | 0 | -5.00M | -3.85M | -1.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Protagenic Therapeutics Inc Stock (PTIX) Latest News
Chartists See Breakout Potential in Protagenic Therapeutics Inc.July 2025 Selloffs & Daily Stock Trend Watchlist - thegnnews.com
Visualizing Protagenic Therapeutics Inc. stock with heatmapsJuly 2025 Review & Consistent Profit Trade Alerts - Newser
Protagenic Therapeutics Inc. Equity Warrant stock momentum explainedJuly 2025 Gainers & Free Reliable Trade Execution Plans - Newser
Is Protagenic Therapeutics Inc. Equity Warrant forming a bottoming base2025 Market Outlook & Community Supported Trade Ideas - Newser
Analyzing drawdowns of Protagenic Therapeutics Inc. Equity Warrant with statistical toolsEarnings Performance Report & Stepwise Entry and Exit Trade Signals - Newser
How hedge fund analytics apply to Protagenic Therapeutics Inc. Equity Warrant stockMarket Activity Recap & Daily Volume Surge Signals - Newser
Real time breakdown of Protagenic Therapeutics Inc. Equity Warrant stock performancePortfolio Performance Summary & AI Forecasted Entry/Exit Points - Newser
What moving averages say about Protagenic Therapeutics Inc. Equity Warrant - Newser
How to read the order book for Protagenic Therapeutics Inc.Market Trend Report & Growth Focused Entry Reports - Newser
Is Protagenic Therapeutics Inc. meeting your algorithmic filter criteriaJuly 2025 Drop Watch & Accurate Intraday Trading Signals - Newser
How to use a screener to detect Protagenic Therapeutics Inc. breakoutsWeekly Trend Report & Low Drawdown Momentum Ideas - Newser
Measuring Protagenic Therapeutics Inc. Equity Warrant’s beta against major indicesFed Meeting & AI Powered Buy and Sell Recommendations - Newser
How to recover losses in Protagenic Therapeutics Inc. Equity Warrant stockWeekly Stock Summary & Entry Point Confirmation Signals - Newser
What MACD and RSI say about Protagenic Therapeutics Inc. Equity WarrantGap Up & Low Risk Entry Point Guides - Newser
Protagenic Therapeutics Inc. stock outlook for YEARMarket Sentiment Report & Reliable Price Action Trade Plans - Newser
Intraday pattern recognizer results for Protagenic Therapeutics Inc. Equity WarrantJuly 2025 Highlights & Safe Swing Trade Setup Alerts - Newser
Can a trend reversal in Protagenic Therapeutics Inc. lead to recoveryWeekly Trend Summary & Entry Point Confirmation Signals - Newser
Can Protagenic Therapeutics Inc. Equity Warrant recover in the next quarterTrade Risk Assessment & Precise Entry and Exit Recommendations - Newser
Using fundamentals and technicals on Protagenic Therapeutics Inc. Equity WarrantJuly 2025 Chart Watch & Low Drawdown Investment Ideas - Newser
Will Protagenic Therapeutics Inc. Equity Warrant outperform the marketJuly 2025 Market Mood & Safe Entry Momentum Tips - Newser
Protagenic Therapeutics Inc. Equity Warrant Earnings Report Breakdown: What Investors Should KnowJuly 2025 Update & Short-Term Trading Opportunity Alerts - Newser
Can a trend reversal in Protagenic Therapeutics Inc. Equity Warrant lead to recovery2025 Big Picture & Long-Term Growth Stock Strategies - Newser
Protagenic Therapeutics Inc. Flashes Rebound Signal in Oversold ConditionJuly 2025 Chart Watch & Real-Time Market Trend Scan - metal.it
Will Protagenic Therapeutics Inc. outperform the market2025 Institutional Moves & Weekly Top Performers Watchlists - Newser
How to escape a deep drawdown in Protagenic Therapeutics Inc. Equity WarrantWeekly Profit Analysis & Free High Accuracy Swing Entry Alerts - Newser
Protagenic Therapeutics Inc. Equity Warrant stock outlook for YEARJuly 2025 Analyst Calls & AI Powered Buy and Sell Recommendations - Newser
Competitive Positioning of Protagenic Therapeutics Inc.: Is It Leading or LaggingJuly 2025 Movers & Safe Entry Point Identification - Newser
Key External Factors That Drive Protagenic Therapeutics Inc. Equity Warrant Stock Price MovementsFed Meeting & Weekly High Potential Stock Alerts - Newser
Protagenic Therapeutics Inc. Equity Warrant stock trend forecastJuly 2025 Weekly Recap & Technical Buy Zone Confirmations - Newser
Ranking Protagenic Therapeutics Inc. Equity Warrant among high performing stocks via toolsJuly 2025 Trends & Low Risk Profit Maximizing Plans - Newser
Understanding Protagenic Therapeutics Inc.’s price movementJuly 2025 Sentiment & Accurate Technical Buy Alerts - Newser
Advanced analytics toolkit walkthrough for Protagenic Therapeutics Inc. Equity WarrantBreakout Watch & Risk Controlled Stock Pick Alerts - Newser
Is it too late to sell Protagenic Therapeutics Inc. Equity Warrant2025 Dividend Review & Fast Momentum Stock Entry Tips - Newser
Can volume confirm reversal in Protagenic Therapeutics Inc.Trade Exit Summary & Safe Entry Zone Identification - Newser
Key metrics from Protagenic Therapeutics Inc.’s quarterly dataQuarterly Portfolio Report & Consistent Profit Trading Strategies - Newser
Chart based analysis of Protagenic Therapeutics Inc. Equity Warrant trends2025 Sector Review & Weekly High Conviction Ideas - Newser
Protagenic Therapeutics Restructures to Focus on PT00114 - MSN
Volume spikes in Protagenic Therapeutics Inc. Equity Warrant stock – what they meanWeekly Investment Report & Community Trade Idea Sharing - Newser
Sentiment analysis tools applied to Protagenic Therapeutics Inc. Equity WarrantMarket Growth Review & High Conviction Investment Ideas - Newser
How to integrate Protagenic Therapeutics Inc. Equity Warrant into portfolio analysis toolsTrade Ideas & Verified Chart Pattern Trade Signals - Newser
Protagenic Therapeutics Inc Stock (PTIX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):